Estimates of future company reported earnings per share, for an upcoming quarter, fiscal year or long-term earnings growth rate. Consensus earnings estimates are the average expectations of professional analysts. If a stock fails to match earnings estimates, it usually gets creamed. That's called a "negative surprise." If a company "beats" estimates it's called an "upside surprise."
Aravive Higher on Progress in Phase 1b Trial of Kidney-Cancer Drug
Aravive shares jumped after the oncology-drug specialist reported progress in a trial of a drug to treat kidney cancer.